<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p28" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_28{left:130px;bottom:1195px;letter-spacing:0.21px;}
#t2_28{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_28{left:128px;bottom:1109px;letter-spacing:-0.18px;}
#t4_28{left:238px;bottom:1109px;letter-spacing:-0.21px;}
#t5_28{left:141px;bottom:1068px;letter-spacing:-0.1px;}
#t6_28{left:250px;bottom:1069px;letter-spacing:-0.01px;}
#t7_28{left:141px;bottom:1012px;letter-spacing:-0.29px;}
#t8_28{left:250px;bottom:1032px;letter-spacing:-0.01px;}
#t9_28{left:250px;bottom:1012px;letter-spacing:-0.01px;}
#ta_28{left:250px;bottom:977px;letter-spacing:-0.04px;}
#tb_28{left:238px;bottom:932px;letter-spacing:-0.01px;}
#tc_28{left:238px;bottom:913px;letter-spacing:-0.01px;}
#td_28{left:238px;bottom:893px;letter-spacing:-0.01px;}
#te_28{left:238px;bottom:874px;letter-spacing:-0.01px;}
#tf_28{left:238px;bottom:854px;letter-spacing:-0.01px;}
#tg_28{left:238px;bottom:835px;letter-spacing:-0.01px;}
#th_28{left:238px;bottom:781px;letter-spacing:-0.01px;}
#ti_28{left:238px;bottom:761px;letter-spacing:-0.01px;}
#tj_28{left:238px;bottom:742px;letter-spacing:-0.01px;}
#tk_28{left:238px;bottom:723px;letter-spacing:-0.01px;}
#tl_28{left:238px;bottom:703px;letter-spacing:-0.01px;}
#tm_28{left:238px;bottom:684px;letter-spacing:-0.01px;}
#tn_28{left:238px;bottom:630px;letter-spacing:-0.01px;}
#to_28{left:238px;bottom:610px;letter-spacing:-0.01px;}
#tp_28{left:238px;bottom:591px;letter-spacing:-0.01px;}
#tq_28{left:238px;bottom:571px;letter-spacing:-0.01px;}
#tr_28{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_28{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_28{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_28{font-size:18px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_28{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_28{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_28{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_28{font-size:10px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts28" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg28Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg28" style="-webkit-user-select: none;"><object width="908" height="1286" data="28/28.svg" type="image/svg+xml" id="pdf28" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_28" class="t s0_28">4.1. Prognostic and predictive factors </span><span id="t2_28" class="t s1_28">28 </span>
<span id="t3_28" class="t s2_28">4.1.1. </span><span id="t4_28" class="t s2_28">Other prognostic factors </span>
<span id="t5_28" class="t s3_28">4.2. </span><span id="t6_28" class="t s4_28">Consensus-based statement </span>
<span id="t7_28" class="t s5_28">EEC </span>
<span id="t8_28" class="t s4_28">In contrast to oropharyngeal carcinoma, HPV status does not play a role as a </span>
<span id="t9_28" class="t s4_28">prognostic factor in laryngeal carcinoma </span>
<span id="ta_28" class="t s6_28">Strong consensus: 100% </span>
<span id="tb_28" class="t s4_28">The detection of human papillomaviruses (HPV), especially HPV16, which is associated with a </span>
<span id="tc_28" class="t s4_28">better prognosis in oropharyngeal carcinoma and has therefore been included in the TNM </span>
<span id="td_28" class="t s4_28">Classification of Malignant Tumours [56], does not play a significant role as a prognostic factor </span>
<span id="te_28" class="t s4_28">in laryngeal carcinoma [57]. Several retrospective studies with laryngeal carcinoma patients </span>
<span id="tf_28" class="t s4_28">show that neither the detection of p16(INK4A) as an HPV surrogate marker nor HPV E6/E7 </span>
<span id="tg_28" class="t s4_28">mRNA significantly correlates with survival [58, 59]. </span>
<span id="th_28" class="t s4_28">In recent decades, the expression of numerous proteins and RNAs as well as the presence/ </span>
<span id="ti_28" class="t s4_28">absence of specific genomic and epigenetic alterations have been investigated in </span>
<span id="tj_28" class="t s4_28">retrospective studies and correlated with the response to therapy or the prognosis of patients </span>
<span id="tk_28" class="t s4_28">with laryngeal carcinoma. However, to date, no prognostic and/or predictive biomarker or </span>
<span id="tl_28" class="t s4_28">biomarker pattern has been established as part of routine clinical diagnostics and thus used </span>
<span id="tm_28" class="t s4_28">for therapy decisions. </span>
<span id="tn_28" class="t s4_28">In this context, current studies focus in particular on the detection of genetic or epigenetic </span>
<span id="to_28" class="t s4_28">aberrations in order to identify patients at high risk for treatment failure or to establish </span>
<span id="tp_28" class="t s4_28">innovative strategies in the sense of personalized therapy [60, 61]. However, initial promising </span>
<span id="tq_28" class="t s4_28">data must first be validated in larger prospective studies. </span>
<span id="tr_28" class="t s0_28">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
